- Home
- Software Solutions
- Resources
- Corporate
A Study of Ranibizumab Administered Monthly or on an As-Needed Basis in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
Sponsors:
| Phases:
| |
| Indications | Acronym: HARBOR | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 1100 | |
Additional information about NCT00891735.